Significantly elevated levels of VCAM-1 and ICAM-1 have been detected in both plasma and CSF samples from AD subjects compared to controls and MCI patients [17,22,23,60,64,65,66]. This evidence concerns the gene VCAM1 and Alzheimer disease.